Serine

Serine

SCHEMBL6532613

NC(=O)O.NC(CO)C(=O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A1 P43005 4/20 0.54
▸ ALOX15 P16050 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ SLC7A11 Q9UPY5 1/20 0.50
▸ SLC1A3 P43003 3/20 0.46
▸ SLC1A2 P43004 3/20 0.46
▸ GSR P00390 2/20 0.46
▸ GRIK1 P39086 2/20 0.46
▸ GRIK2 Q13002 2/20 0.46
▸ GRM1 Q13255 2/20 0.46
▸ GRM2 Q14416 2/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ SLC7A5 Q01650 1/20 0.46
▸ GRM8 O00222 1/20 0.46
▸ GRM6 O15303 1/20 0.46
▸ GRIN2D O15399 1/20 0.46
▸ GRIN3B O60391 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Serine SCHEMBL6532615 1.00 SLC1A1 (0.54) SLC1A1ALOX15BLMPMP22KMT2A
Serine SCHEMBL15878648 0.94 SLC1A1 (0.54) SLC1A1ALOX15BLMPMP22KMT2A
Serine SCHEMBL15878649 0.94 SLC1A1 (0.54) SLC1A1ALOX15BLMPMP22KMT2A
Serine SCHEMBL6929773 0.94 SLC1A1 (0.59) SLC1A1ALOX15BLMPMP22KMT2A
Serine SCHEMBL2023739 0.94 SLC1A1 (0.59) SLC1A1ALOX15BLMPMP22KMT2A
Serine SCHEMBL1332181 0.94 — —
(D)-Serine SCHEMBL6038168 0.94 SLC1A1 (0.59) SLC1A1ALOX15BLMPMP22KMT2A
Serine SCHEMBL2023740 0.94 SLC1A1 (0.59) SLC1A1ALOX15BLMPMP22KMT2A
Serine SCHEMBL6520918 0.94 SLC1A1 (0.59) SLC1A1ALOX15BLMPMP22KMT2A
(D)-Serine SCHEMBL43094 0.94 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120270847-A1 NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIATES AND USES THEREOF SHIRE LLC (US) 2012-10-25 — — US disclosed
US-20110015182-A1 NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIOIDS AND USES THEREOF SHIRE LLC 2011-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015182-A1 NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIOIDS AND USES THEREOF OPRL1, OPRM1, DNPEP SLC1A1 24/4885ALOX15 1012/4885BLM 4883/4885
US-20120270847-A1 NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIATES AND USES THEREOF OPRL1, OPRM1, DNPEP SLC1A1 34/4885ALOX15 1163/4885BLM 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback